4//SEC Filing
Englebright Jane D. 4
Accession 0001209191-21-049480
CIK 0000860730other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 7:26 PM ET
Size
11.2 KB
Accession
0001209191-21-049480
Insider Transaction Report
Form 4
Englebright Jane D.
SVP and Chief Nursing Officer
Transactions
- Sale
Common Stock
2021-07-30$249.43/sh−2,900$723,352→ 4,427 total - Sale
Common Stock
2021-08-02$249.57/sh−409$102,073→ 4,018 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.26 to $249.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.50 to $249.68, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Issuer
HCA Healthcare, Inc.
CIK 0000860730
Entity typeother
Related Parties
1- filerCIK 0001632834
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 7:26 PM ET
- Size
- 11.2 KB